Metraipolis › archive › dc_43d9db944d8d

Allogeneic islet products for type 1 diabetes: Navigating nonclinical and manufacturing regulatory expectations — Europe PMC PMID:42409021

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42409021
DOI
10.1016/j.stemcr.2026.102998
License (as archived)
solo-consultazione
Archived
2026-10-18T11:08:04.643Z
SHA-256 of the archived text
ca1d7dbc5ec960f877ef24d45246a5ea1d6428e3872f0b5ac65ad435e36047e4
Stable URL of this page
https://metraipolis.com/documento/dc_43d9db944d8d

How to cite

Allogeneic islet products for type 1 diabetes: Navigating nonclinical and manufacturing regulatory expectations — Europe PMC PMID:42409021 — Europe PMC (en), https://europepmc.org/article/MED/42409021 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43d9db944d8d (Metraipolis archive dc_43d9db944d8d, sha256 ca1d7dbc5ec960f877ef24d45246a5ea1d6428e3872f0b5ac65ad435e36047e4)
BibTeX
@misc{dc43d9db944d8d,
  title = {Allogeneic islet products for type 1 diabetes: Navigating nonclinical and manufacturing regulatory expectations — Europe PMC PMID:42409021},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42409021},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43d9db944d8d; sha256 ca1d7dbc5ec960f877ef24d45246a5ea1d6428e3872f0b5ac65ad435e36047e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42409021. Agents can read the archived copy with the MCP tool read_document.